Kimelman & Baird, LLC Viatris Inc Transaction History
Kimelman & Baird, LLC
- $1.21 Trillion
- Q2 2024
A detailed history of Kimelman & Baird, LLC transactions in Viatris Inc stock. As of the latest transaction made, Kimelman & Baird, LLC holds 1,301 shares of VTRS stock, worth $16,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,301Holding current value
$16,860% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,091Shares Held
971MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.82 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.2 Billion0.02% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$812 Million4.18% of portfolio
-
State Street Corp Boston, MA62.1MShares$805 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$736 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.7B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...